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Abstract 
Extremely low birth weight premature infants have been known for many years to have limited antioxidant protective capacity, especially with 
reference to those antioxidant components which do not cross the placenta until the third trimester of gestation. In this study the total antioxidant 
activity and the concentrations of individual antioxidants in plasma from premature neonates (27 f 2 weeks gestation) compared to term babies (3841 
weeks gestation) have been examined. The results show elevated levels of ascorbate at birth in the plasma of premature neonates compared with those 
of term babies, but the total plasma antioxidant status of the premature babies is significantly lower than that of term babies. At 5 days post-partum 
the ascorbate levels are within the normal adult range and plasma bilirubin levels are considerably enhanced in both groups, while the total plasma 
antioxidant status of the premature neonates has increased. Analysis of the relationship between the total plasma antioxidant activity and the bilirubin 
concentration show a direct, highly significant correlation for the term group, r* = 0.774, consistent with significance of bilirubin as a plasma 
antioxidant. 
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1. Introduction 
Of the range of antioxidants in the human body, those 
located intracellularly are appropriate for dealing with 
aberrant generation of free radicals, whereas those 
placed extracellularly are more appropriate for intercept- 
ing propagating peroxidative mechanisms and for bind- 
ing metal ions and delocalised haem proteins (reviewed 
in [l]). The antioxidant defences of human plasma in- 
clude ascorbate [2], protein thiols [3], bilirubin [4], urate 
[5], and ol-tocopherol [6], as well as the proteins involved 
in iron removal, namely, caeruloplasmin [7] and transfer- 
rin [ 11. Oxidative stress is defined as a disturbance of the 
pro-oxidant/antioxidant balance in favour of the former 
[8]. Previous studies have shown that the total plasma 
antioxidant activity is decreased, compared to normal 
levels, in premature neonates [9], in smokers and asth- 
matics [lo]. 
When, shortly after birth, premature infants require 
prolonged mechanical ventilatory support with high lev- 
els of oxygen therapy, the barotrauma, in combination 
with immature development of the lung antioxidant en- 
zyme system, contributes towards the development of 
bronchopulmonary dysplasia or chronic lung disease of 
the newborn. 
Extremely low birth weight (ELBW = L 1000 g, 2 28 
weeks gestation) premature infants have been known for 
many years to have limited antioxidant protective capac- 
ity. In particular, their vitamin E, B-carotene, caeru- 
loplamin, a-antiproteinase, thiol-containing amino acid 
*Corresponding author. Fax: (44) (71) 955 4983. 
levels have all been shown to be deficient [l l-141, mainly 
because these components do not cross the placenta until 
the third trimester of gestation. In addition, deficiencies 
in the trace metals selenium, copper and zinc, essential 
components of the antioxidant enzymes glutathione per- 
oxidase and superoxide dismutase, have been reported 
[151. 
In this study we have examined the total antioxidant 
activity and the concentrations of individual antioxi- 
dants of plasma from premature neonates (27 k 2 weeks 
gestation) compared with those of term babies. The re- 
sults show that premature neonates under the conditions 
studied have considerably higher ascorbate levels at birth 
compared to term babies, but their total plasma antioxi- 
dant status is significantly lower. The data also show that 
at 5 days post-partum the levels of the total antioxidant 
activity and ascorbate normalise and that an important 
contributing factor to the former is the bilirubin concen- 
tration in plasma. 
2. Materials and methods 
Ethical permission was obtained from the Ethics Committee of St. 
Thomas’s Hospital. 
The study group consisted of 31 pretetm infants and 16 term infants 
who were delivered in the maternity unit at St. Thomas’s Hospital. The 
pre-term infants had a gestational age of between 24 and 33 weeks with 
birth weight ranging from 4461800 g. The pre-tenn infants were all 
admitted to the neonatal intensive care unit at St. Thomas’s Hospital. 
The term infants had a gestational age between 37 and 41 weeks and 
their birth weights were between 2200 and 3920 g. 
Umbilical cord blood samples were obtained from I6 term babies and 
31 pre-term babies within 5 min after the delivery of the placenta. Blood 
was also collected from each baby on day 5. 
Blood was gently withdrawn into heparinised tubes and immediately 
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centrifuged (1000 x g, 15 min). The plasma was separated. 200 ~1 of 
plasma was added to 0.8 ml of 10% trichloroacetic acid, to obtain a 
protein-free extract for ascorbate analysis, and stored at -70°C. Other 
portions of the plasma were retained for total antioxidant activity, 
mate, albumin, ascorbate, a-tocopherol and stored at -20°C. 
Total antioxidant activity was measured by the ABTS method on a 
Cobas Bio centrifugal analyser [9]. This method uses a spectrophoto- 
metric end point and commonly available laboratory reagents; the 
extent of quenching by antioxidants of the ABTS radical cation gener- 
ated from interaction with activated myoglobin at 734 nm is measured. 
Uric acid and albumin were also measured by the Cobas Bio centrifugal 
analyser methods (uricaselrl aminophenazone and BCP). Plasma 
a-tocopherol was determined by normal-phase HPLC [16]. Total 
plasma ascorbate was determined by spectrophotometric analysis using 
2,4 dinitrophenylhydrazine [I71 and bilirubin according to Fog and 
Bakken [18]. 
3. Results 
The characteristics of the premature babies are tabu- 
lated in Table 1. The correlation between birth weight 
and total antioxidant activity is shown in Fig. 1 
(r2 = 0.43) and confirms the previous proposition of a 
relationship between them [ 191. 
Measurement of the levels of the major antioxidants 
in the plasma of premature neonates compared with term 
neonates (Table 2) shows that the two groups have 
Table I 
Characteristics of premature neonates 
Baby Birth weight Sex Phototherapy Gestation 140 
TAL 1 
BAL 31 
HAR 2 
AND 3 
SIM 4 
CRA 5 
INN 6 
ECC I 
AM0 8 
CUM 9 
OLU IO 
FRE II 
CRA I2 
SMI 13 
PAT 14 
cot 15 
PER 16 
MON 17 
MOO I8 
WHI I9 
BAC I 20 
BAC II 21 
THO 22 
HAL 23 
PAD 24 
JAC I 25 
JAC II 26 
MAR 27 
JAC 28 
JER 29 
WAL 30 
1.45 
0.840 
M 
0.700 
F 
M 
0.942 F 
I .40 F 
1.80 F 
0.730 F 
0.774 F 
1.73 F 
1.24 F 
0.962 M 
0.446 F 
0.660 M 
1.45 F 
0.952 F 
1.18 M 
1.08 F 
0.580 M 
1.5 M 
0.926 F 
1.67 M 
1.80 M 
1.41 F 
0.970 F 
I .40 F 
0.958 F 
0.990 F 
1.38 M 
0.936 M 
0.980 M 
1.028 F 
Yes (days 3,4,5,6) 
Yes (days 4,5,6,7) 
No 
No 
Yes (days 3,4) 
Yes (days 2,3,4,5) 
Yes (days 3,4,5) 
No 
No 
No 
No 
No 
No 
Yes (days 4,5) 
No 
No 
Yes (days 3,4) 
Yes (days 2,3,4,5) 
No 
No 
No 
No 
No 
Yes (days 3,4) 
Yes (days 5) 
No 
No 
Yes (days 4,5) 
Yes (days 3,4,5) 
No 
29 
24” 
27 
29 
3l+5 
29 
25’2 
32+5 
28 
29” 
28+4 
24” 
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28+4 
28+* 
26+’ 
29+4 
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33+4 
33+4 
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30+5 
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Fig. I. Correlation between total plasma antioxidant activity at birth 
and birth weight in term and pre-term neonates (r* = 0.434). 
no significant differences with respect to bilirubin and 
ol-tocopherol at birth but that the latter is very much 
lower than the adult range. In contrast, the levels of 
albumin and urate are significantly lower in the samples 
from the premature babies, although the urate levels in 
both groups are within the normal reference interval; this 
only applies to the term babies for albumin. 
Ascorbate levels are significantly higher in the prema- 
ture babies at birth than in the term, and the values for 
term babies lie beyond the upper limit of the adult refer- 
ence interval. Although, enhanced ascorbate levels in 
term babies has previously been demonstrated, no differ- 
ences were revealed with premature babies at 32 k 3 
weeks [20]. 
At 5 days post-partum, while the albumin levels are 
not changed significantly in either group, the urate levels 
have significantly declined in the term babies but are still 
within the normal range. The ascorbate levels in both 
groups decreased to values close to the midpoint of the 
normal adult range and the a-tocopherol levels progres- 
sively increase as expected. Hyperbilirubinaemia is ap- 
parent in both groups at 5 days. 
The total plasma antioxidant activities of the pre-term 
babies (27 + 2 weeks) are consistent with our previous 
report on a smaller population, i.e. significantly de- 
pressed (1.25 & 0.09, n = 28) compared to term babies 
(1.44 + 0.08, n = 16) (P < 0.005) whose levels are akin to 
the normal adult range (1.46 & 0.14, n = 312) [9]. After 
5 days the mean value of total antioxidant activity had 
risen to values not significantly different from those of 
the term babies (pre-term, 1.45 + 0.08, n = 28; term, 
1.49 & 0.15, n = 15). 
In order to assess the relative importance of the 
plasma antioxidant profile in relation to the total antiox- 
idant activity, the concentration of each of the antioxi- 
dants measured has been related to its overall antioxi- 
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Table 2 
199 
Plasma antioxidant levels (,uM) of premature and term babies 
Values at birth 
Premature Term 
Values at day 5 
Premature Term 
Normal adult 
Albumin 
Uric acid 
Ascorbate 
a-Tocopherol 
Bilirubin 
380 + 83 [22] 482 f 64 [14] 370 + 80 [19] 530 [2] 535-760 midpt 640 
P < 0.005 
267 f 107 [24] 413 + 103 [I51 196 + 69 [27] 191 f 84 [14] 180420 midpt 300 
P < 0.005 
164 f 60 [271 123 + 28 [I61 65 k 25 [28] 84 f 18 [16] 34111 midpt 73 
P < 0.005 P < 0.05 
6.8 f 4.4 [lo] 4.4 f 1.4 [IO] IO f 5.6 [23] 13.7 f 4 [8] 1444 midpt 29 
23 f 10 [26] 20 f 10 [16] 67 +_ 47 [23] 126 + 92 [16] < 20 midpt 10 
dant potential [9] and expressed as relative proportions 
to the sum of the contributions from albumin, urate, 
ascorbate, ol-tocopherol and bilirubin (the major radical 
scavenging antioxidants in plasma). The results (Table 
3) show that for the pre-term and term babies, the com- 
bined relative contributions of urate, ascorbate and 
bilirubin at birth are the same, but the higher relative 
ascorbate and lower relative urate in the former are pro- 
nounced. 
4. Discussion 
Other workers [20] have measured the concentration 
of various plasma antioxidants of babies at 32 weeks 
gestation compared with term neonates and adults; their 
results revealed no significant differences between 32 + 3 
weeks pre-term and term neonates, but the ascorbate, 
vitamin E and bilirubin were all significantly different 
from adult levels. 
The study described here shows elevated plasma ascor- 
bate levels in the pre-term babies at birth compared to 
term. This may be a marker of the increased prematurity 
of these neonates and might be partly a compensatory 
mechanism for the relatively lower proportions of urate 
(Table 2) although not adequate enough to compensate 
for the lowered total antioxidant activity. Expressing the 
data as relative levels in relation to the major antioxi- 
dants of human plasma emphasises the contribution of 
bilirubin to the antioxidant potential at day 5 for both 
the term and the pre-term infants. 
It is significant to note here that for the term babies 
a clear correlation is demonstrable (Fig. 2) between the 
total antioxidant activity and the bilirubin levels at day 
5 (2 = 0.774) showing that the bilirubin concentration 
has a relatively greater impact on the total antioxidant 
activity. This demonstration of the importance of biliru- 
bin as an antioxidant strengthens the proposal [21] that 
moderately increased plasma bilirubin levels may be pos- 
itively favourable to infants under oxidative stress. For 
the premature babies the correlation is apparently much 
less significant (12 = 0.30), but this may be confounded 
by the phototherapy treatment which would influence 
the bilirubin levels. 
The comparative data of relative levels of antioxidants 
suggest hat the overall deficiency in the total plasma 
antioxidant capacities of the pre-term compared with 
term babies may stem from the contributions from the 
‘masked’ oxidative stress factors which might include the 
iron status and the iron-binding proteins, or phagocytic 
activity. In the context of the iron status, several studies 
have demonstrated the presence of ‘available’ iron in the 
plasma of pre-term and term neonates [22-241, although 
the former will be more pronounced due to several fac- 
tors, including transfusion. It has been proposed by oth- 
ers that iron-induced oxidative stress may play a role in 
the pathogenesis of oxygen radical diseases of prema- 
turity [25]. Much work has also focussed on the iron 
status of the newborn and the importance of transferrin 
and caeruloplasmin levels in the context of antioxidant 
1 .8 r 
1.2’ I , I 
0.0 0.1 0.2 0.3 
bilirubin mM 
Fig. 2. Correlation between total plasma antioxidant activity (mM) and 
plasma bilirubin concentrations (mM) in term neonates, day 5 
(rz = 0.774). 
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Table 3 
Comparative relative proportions of plasma antioxidants between pre- 
mature and term neonates expressed as a percentage of the total antiox- 
idants 
Albumin Urate Ascorbate a-Toco- 
pherol 
Bilirubin 
TEAC value 0.63 I .02 0.99 0.97 1.5 
Reference 49 31.5 9.5 3 I 
level [9] 
Term at birth 34.5 47.8 13.8 0.5 3.4 
Term-day5 41 24.1 10.2 1.6 23 
Prem at birth 33.5 38.1 22.7 0.9 4.8 
Prem - day 5 30.8 26.4 8.5 1.2 33.1 
activity [25]. However, exchange transfusion has been 
shown to have no influence on the TRAP value of 
plasma [26] in a gorup of new borns with rhesus haemo- 
lytic disease despite decreases in vitamin C and bilirubin, 
even though iron and ferritin levels declined and the 
caeruloplasmin and transferrin levels and the iron-bind- 
ing capacity of the plasma increased. 
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